Vitamin B3 and Reduced Intraocular Pressure

Doses used in studies

mg/day: 500 (median 500, IQR 500–500) — 1 study

Time to effect

Median: 6 months · IQR 6 months–6 months · Range 6 months–6 months — Reported in 1 of 1 study

1 of 1 paper

Changes in Quality of Life Among Glaucoma Patients Following Six Months of Niacinamide Supplementation.

2025-08-27
Clinical Trial
Nutrients 17(17)
- Constantin Alin Nicola
- Maria Cristina Marinescu
- Anne Marie Firan
- Georgica Tartea
- Mihaela Simona Naidin
- Radu Constantin Ciuluvica
- Marina Daniela Dimulescu
- Nicoleta Mirela Voicu
- Carmen Marinela Mihailescu
- Andreea-Daniela Meca
- Maria Bogdan
- Adina Turcu-Stiolica

PubMed: 40944166
DOI: 10.3390/nu17172775

5 Insights on

Reduced Intraocular Pressure

High evidence
Rigorous Journal
Clinical

B3 treatment resulted in a significant reduction in intraocular pressure in both eyes over 6 months (mean difference = 0.53, 95% CI: [0.21, 0.86] in the left eye and mean difference = 0.36, 95% CI: [0.04, 0.68] in the right eye)

Effect: Beneficial
Effect size: Small
Significant: Yes
Dose: 500 mg daily